The stock has gained 31 percent over the past year, giving the company a market value of $59 million. The company plans on marketing the implants in the second half of 2011, according to the report.
Read the Bloomberg Businessweek report on Mazor Robotics.
Read other coverage on Mazor:
– Mazor’s SpineAssist Clinical Study Shows 98% Accuracy in Implant Placement
– Mazor Receives FDA Approval for SpineAssist and C-InSight For Spine Surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
